Methotrexate 1g/vial; pwd for IV, IM, intra-arterial, or intrathecal administration after dilution; preservative-free. Non-metastatic osteosarcoma in patients who have undergone surgical resection or ...

Teva announced that the FDA has approved preservative-free Methotrexate injection, USP. Methotrexate, an antimetabolite, is a folic acid antagonist used to treat certain types of cancer including ...

The US Food and Drug Administration (FDA) has approved a subcutaneous injectable methotrexate delivered in an auto-injector (Rasuvo, Medac Pharma) for rheumatoid arthritis (RA), polyarticular-course ...

Methotrexate injection device approved The FDA has approved Otrexup for adults with active, severe rheumatoid arthritis or psoriasis who haven't responded first line therapy and children with active ...

October 29, 2010 — Sandoz is voluntarily recalling all lots of 50 mg/2 mL and 250 mg/10 mL methotrexate injection after discovering glass flakes in some vials of the product, the company announced ...

NEW YORK CITY -- Postoperative intravitreal methotrexate for retinal detachment led to a significant reduction in reoperation and improved visual acuity, a retrospective chart review showed. The ...

LONG BEACH, Calif. -- Methotrexate, during and after surgery for primary retinal detachment, has produced "amazing" early results in preventing proliferative vitreoretinopathy (PVR), according to ...

LEXINGTON, Mass., June 26, 2025--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced receipt of a Special Protocol Assessment Agreement Letter from the U.S. Food and ...